Jing L. Marantz - 31 Jan 2022 Form 4 Insider Report for Krystal Biotech, Inc. (KRYS)

Role
Chief Business Officer
Signature
/s/ Krish Krishnan, as Attorney-in-Fact
Issuer symbol
KRYS
Transactions as of
31 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 16:27:14 UTC
Previous filing
09 Dec 2021
Next filing
27 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRYS Stock Option (Right to Buy) Award $0 +205,000 $0.000000 205,000 31 Jan 2022 Common Stock 205,000 $59.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were awarded on January 31, 2022 and vest in four equal annual installments beginning on January 31, 2023.